PEPLIN

Welcome to the Brand page for “PEPLIN”, which is offered here for In the statement, line 17, cardio-active agents should be deleted.;vaccines; pharmaceuticals and medical preparations for the treatment of cancer; diagnostic preparations for medical purposes; plant derived therapeutic agents for the treatment and prevention of dermatological, inflammatory conditions; anti-cancer preparations; therapeutic agents for cancer treatment, particularly for use topically, intra-lesionally and/or systemically; pharmaceuticals for treatment or prevention of dermatological, respiratory and/or inflammatory conditions;pharmaceutical, medical, biological and/or chemical research and development; consultancy services in relation to pharmaceutical, medical, biological and/or chemical research; research services for drug identification and evaluation and development, including in relation to anti-cancer agents, particularly drugs of plant origin; scientific identification, evaluation and/or development of drugs of plant origin; research and development services for therapeutic agents for use in dermatological, respiratory and/or inflammatory conditions;.

Its status is currently believed to be active. Its class is unavailable. “PEPLIN” is believed to be currently owned by “Peplin, Inc.”


Owner:
PEPLIN, INC.
Owner Details
Description:
In the Statement, line 17, CARDIO-ACTIVE AGENTS should be deleted.;Vaccines; pharmaceuticals and medical preparations for the treatment of cancer; diagnostic preparations for medical purposes; plant derived therapeutic agents for the treatment and prevention of dermatological, inflammatory conditions; anti-cancer preparations; therapeutic agents for cancer treatment, particularly for use topically, intra-lesionally and/or systemically; pharmaceuticals for treatment or prevention of dermatological, respiratory and/or inflammatory conditions;Pharmaceutical, medical, biological and/or chemical research and development; consultancy services in relation to pharmaceutical, medical, biological and/or chemical research; research services for drug identification and evaluation and development, including in relation to anti-cancer agents, particularly drugs of plant origin; scientific identification, evaluation and/or development of drugs of plant origin; research and development services for therapeutic agents for use in dermatological, respiratory and/or inflammatory conditions;
Categories: STATEMENT